Cargando...

In vivo hyperspectral imaging of microvessel response to trastuzumab treatment in breast cancer xenografts

HER2-amplified (HER2 + ) breast cancers are treated with the anti-HER2 monoclonal antibody trastuzumab. Although trastuzumab reduces production of the angiogenic factor VEGF in HER2 + tumors, the acute and sustained effects of trastuzumab on the tumor vasculature are not understood fully, particular...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: McCormack, Devin R., Walsh, Alex J., Sit, Wesley, Arteaga, Carlos L., Chen, Jin, Cook, Rebecca S., Skala, Melissa C.
Formato: Artigo
Idioma:Inglês
Publicado: Optical Society of America 2014
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4102362/
https://ncbi.nlm.nih.gov/pubmed/25071962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1364/BOE.5.002247
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!